1. Home
  2. ELTK vs CNTX Comparison

ELTK vs CNTX Comparison

Compare ELTK & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

N/A

Current Price

$5.98

Market Cap

53.8M

Sector

Technology

ML Signal

N/A

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

N/A

Current Price

$0.19

Market Cap

47.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTK
CNTX
Founded
1970
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.8M
47.7M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
ELTK
CNTX
Price
$5.98
$0.19
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $4.14
AVG Volume (30 Days)
4.1K
★ 1.1M
Earning Date
11-17-2026
11-17-2026
Dividend Yield
★ 3.16%
N/A
EPS Growth
N/A
★ 17.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.01
$0.19
52 Week High
$11.59
$3.62

Technical Indicators

Market Signals
Indicator
ELTK
CNTX
Relative Strength Index (RSI) 31.34 31.12
Support Level N/A N/A
Resistance Level $9.42 $0.36
Average True Range (ATR) 0.36 0.02
MACD -0.03 0.00
Stochastic Oscillator 7.51 21.12

Price Performance

Historical Comparison
ELTK
CNTX

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: